Tirzepatide

Product

Dual GLP-1/GIP agonist marketed as Mounjaro and Zepbound by Eli Lilly

2 stories

Eli Lilly's Obesity Drug Retatrutide Succeeds in Late-Stage Diabetes Trial

Two Deaths Reported to Regulators Potentially Linked to Weight-Loss Injections